Glatiramer is indicated for the reduction of the frequency of relapses in ambulatory patients with relapsing-remitting multiple sclerosis and is administered as a subcutaneous injection once daily.
Glatiramer acetate injection (Copaxone, Teva/Sanofi-Aventis) can now be stored for up to one month at room temperature following approval of the application that extended the room temperature storage life from the previously approved seven days. Glatiramer is indicated for the reduction of the frequency of relapses in ambulatory patients with relapsing-remitting multiple sclerosis and is administered as a subcutaneous injection once daily.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.